Funding supports research, training, and career development opportunities to accelerate scientific and medical breakthroughs that improve human health.
Duke researchers, including CAGPM's Chris Woods, Ryan Shaw, and Jessilyn Dunn, are investigating whether data from your smartphone and smartwatch can help determine if you have COVID-19 and how severe the infection could get. Their work has the potential to help avoid future pandemics, but they need more participants to enroll.
CAGPM's Christopher Woods among Duke experts offer a bracing word of caution: The virus will remain dangerous and require a stronger global vaccination effort, and people should remain vigilant, safe and responsible
Ephraim Tsalik and Duke researchers are finding the testing tool could help clinicians know when to correctly prescribe antibiotics
Applications are due by Feb. 11, 2022
The deadline for applications is Feb. 15, 2022
Micah McClain, MD, has received an award from Biomeme, Inc. for a project entitled "Biomeme Franklin ISP SARS-CoV-2 + Influenza Multiplexed RT-PCR Test Point of Care Study including Saletto Oral Fluid Collection."
Lori Orlando, MD, MHS, has received an award (1R01-HG011794-01) from the National Institutes of Health for a project entitled "Deploying a genomic-medicine risk assessment model for diverse primary care populations and settings."
Geoffrey Ginsburg, MD, PhD has received an award (5U01-HG010225-04S1) from the National Institutes of Health for a project entitled "The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination."
Ephraim Tsalik, MD, PhD, has received an award (W81XWH2110741-PR201197) from the Department of Defense for a project entitled "Rapid, point-of-care, host gene expression test for presymptomatic viral infection and to distinguish bacterial from viral illness."
Christopher Woods, MD, received a sub-award (W911QY-19-9-0006) through the Henry M. Jackson Foundation for a project entitled "Prophylaxis and Treatment of COVID19 Adaptive Platform Trial (PROTECT-APT)." (June 2021, Sponsored Research)
Ricardo Henao, Tom Burke, Emily Ko, Micah McClain, Christopher Woods, Ephraim Tsalik and co-authors compare three host response strategies to distinguish bacterial and viral etiologies of acute respiratory illness (PLoS One)
Deepak Voora, Rachel Myers, Ilya Zhannikov, and team find biosignatures composed of gene expression data hold promise for personalized antiplatelet therapy in conjunction with current guidelines and risk scores. (AHA Journals/Circulation)
Jeanette McCarthy and co-authors discuss diagnostic performance of Fabric GEM, a new, AI-based, clinical decision support tool for expediting genome interpretation. (Genome Medicine, part of Springer Nature)
Ryan Shaw, Christopher Woods, Jessilyn Dunn and team investigate demographic imbalances discovered in existing BYOD studies and propose a Demographic Improvement Guideline to offset these imbalances (JMIR Publications)
Douglas E. Williamson and co-authors investigate a quantitative approach to PTSD phenotype measurement and incorporation of lifetime trauma exposure (LTE) information to enhance the discovery power of PTSD genome-wide association studies (Biological Psychiatry)
Ryanne Wu, Lori Orlando, and team explore perceptions of the value of knowing one’s family health history (FHH)-based risk and potential implementation of a FHH tool (Journal of Personalized Medicine)
The laboratory brings together expertise in molecular microbiology with genome sciences to develop next-generation diagnostic tests.
We support biobanking activities including IRB, sample collection, processing, storage, bar-coded chain of custody and e-inventory management.